Skip to main content

Table 4 Four-part compositional time-use: associations with adiposity and cardiometabolic risk markers per 30 min one-to-one sedentary time exchanges

From: Substituting device-measured sedentary time with alternative 24-hour movement behaviours: compositional associations with adiposity and cardiometabolic risk in the ORISCAV-LUX 2 study

 

Sedentary time → Sleep period

Sedentary time → Light PA

Sedentary time → MVPA

Waist circumference (cm)

 Model A

− 0.63 (− 0.96 to − 0.29)

− 0.28 (− 0.85 to 0.30)

− 1.09 (− 1.68 to − 0.51)

 Model B

− 0.60 (− 0.93 to − 0.27)

− 0.34 (− 0.91 to 0.23)

− 1.03 (− 1.60 to − 0.45)

Fasting glucose (mg/dL)

 Model A

− 0.24 (− 0.60 to 0.12)

0.27 (− 0.35 to 0.88)

− 1.02 (− 1.64 to − 0.39)

 Model B

− 0.23 (− 0.59 to 0.13)

0.25 (− 0.37 to 0.87)

− 0.99 (− 1.61 to − 0.36)

 Model C

− 0.08 (− 0.43 to 0.27)

0.34 (− 0.27 to 0.94)

− 0.73 (− 1.34 to − 0.12)

Triglycerides (%)

 Model A

− 0.69 (− 1.91 to 0.55)

− 2.07 (− 4.14 to 0.03)

− 1.49 (− 3.59 to 0.65)

 Model B

− 0.62 (− 1.84 to 0.61)

− 2.32 (− 4.38 to − 0.21)

− 1.19 (− 3.30 to 0.96)

 Model C

− 0.02 (− 1.21 to 1.18)

− 1.98 (− 3.97 to 0.06)

− 0.17 (− 2.23 to 1.94)

HDL-c (mg/dL)

 Model A

0.14 (− 0.22 to 0.50)

0.20 (− 0.42 to 0.82)

1.30 (0.68 to 1.93)

 Model B

0.13 (− 0.23 to 0.49)

0.24 (− 0.38 to 0.86)

1.24 (0.61 to 1.87)

 Model C

− 0.06 (− 0.41 to 0.28)

0.13 (− 0.47 to 0.73)

0.91 (0.30 to 1.52)

CCMR (z-score)

 Model A

− 0.07 (− 0.15 to 0.00)

− 0.09 (− 0.22 to 0.05)

− 0.28 (− 0.41 to − 0.14)

 Model B

− 0.07 (− 0.15 to 0.01)

− 0.10 (− 0.24 to 0.03)

− 0.25 (− 0.39 to − 0.12)

Total body fat (%)

 Model A

− 0.29 (− 0.48 to − 0.10)

− 0.42 (− 0.75 to − 0.09)

− 0.65 (− 0.98 to − 0.32)

 Model B

− 0.28 (− 0.47 to − 0.09)

− 0.45 (− 0.77 to − 0.12)

− 0.63 (− 0.96 to − 0.30)

Fasting insulin (%)

 Model A

− 2.56 (− 3.99 to − 1.11)

− 3.29 (− 5.71 to − 0.81)

− 4.71 (− 7.12 to − 2.24)

 Model B

− 2.47 (− 3.89 to − 1.02)

− 3.56 (− 5.97 to − 1.08)

− 4.39 (− 6.81 to − 1.90)

 Model C

− 1.15 (− 2.40 to 0.12)

− 2.90 (− 4.92 to − 0.67)

− 2.16 (− 4.32 to 0.04)

ApoB/A1 ratio

 Model A

− 0.00 (− 0.01 to 0.00)

− 0.01 (− 0.02 to − 0.00)

− 0.00 (− 0.01 to 0.00)

 Model B

− 0.00 (− 0.01 to 0.00)

− 0.01 (− 0.02 to − 0.00)

− 0.00 (− 0.01 to 0.01)

 Model C

0.00 (− 0.00 to 0.01)

− 0.01 (− 0.02 to − 0.00)

− 0.00 (− 0.01 to 0.01)

  1. Model A adjusted for sex, age, education level, season of measurement, smoking status, general health, medication use, and family history of cardiovascular disease or diabetes. Model B further adjusted for dietary factors (total caloric intake, salt and caffeine consumption), depressive symptoms, and sleep quality. Model C further adjusted for waist circumference. The results are β-coefficients (95% confidence intervals) and represent the expected difference in outcomes when reallocating 30 min of sedentary time to another behavior, keeping all other movement behaviours constant at the compositional mean. Data for triglycerides and insulin were on the log scale, the results have been retransformed [(expβ-1)*100] to represent the percentage difference in outcomes per 30 min of time exchanged. Bold font indicates statistically significant associations (p < 0.05).
  2. ApoB/A1 Apolipoprotein B to A1, CCMR Clustered cardiometabolic risk, HDL-c High-density lipoprotein cholesterol, PA Physical activity, MVPA Moderate-to-vigorous physical activity